WMB
55
-7
BLK
61
-5
CAH
69
-3
OMC
35
-4
SO
70
-5
WFC
72
-8
OI
45
-4
ZTS
31
-3
TSN
42
-2
NI
72
-5
ZBH
53
2
VIX
47
17
CMA
55
-6
CFG
78
-8
MCO
67
-8
EW
37
-9
FAST
23
-26
NWS
68
-20
ICE
62
-2
UA
53
-3
WMB
55
-7
BLK
61
-5
CAH
69
-3
OMC
35
-4
SO
70
-5
WFC
72
-8
OI
45
-4
ZTS
31
-3
TSN
42
-2
NI
72
-5
ZBH
53
2
VIX
47
17
CMA
55
-6
CFG
78
-8
MCO
67
-8
EW
37
-9
FAST
23
-26
NWS
68
-20
ICE
62
-2
UA
53
-3
Financhill
Back

Novonesis (Novozymes) B 10K Form

Buy
60

NVZMY
Novonesis (Novozymes) B

Last Price:
$70.43
Seasonality Move:
1.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVZMY News And Ratings

See the #1 stock for the next 7 days that we like better than NVZMY

NVZMY Financial Statistics

Sales & Book Value

Annual Sales: $4.1B
Cash Flow: $53.9M
Price / Cash Flow: 60.45
Annual Sales: $26.07
Price / Book: 2.69

Profitability

EPS (TTM): 1.13730
Net Income (TTM): $522.7M
Gross Margin: $2B
Return on Equity: 6.56%
Return on Assets: 3.97%

Novonesis (Novozymes) B Earnings Forecast

Key Novonesis (Novozymes) B Financial Ratios

  • The Gross Profit Margin over the past 23 years for NVZMY is 47.20%.
  • The Selling, General & Administrative Expenses for NVZMY have been equal to 19.97% of Gross Profit Margin.
  • The Research & Development expenses have been 10.78% of Revenue.
  • The Interest Expense is 24.98% of Operating Income.
  • The Net Earning history of NVZMY is 7.98% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 17 years.

Novonesis (Novozymes) B Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Chemicals
Sector: Materials
Current Symbol: NVZMY
Website: novozymes.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 1.66
Quick Ratio: 1.04

Price-to-Earnings

Trailing P/E Ratio: 96.65
Forward P/E Ratio: 0

NVZMY Technical Analysis vs Fundamental Analysis

Buy
60
Novonesis (Novozymes) B (NVZMY) is a Buy

Is Novonesis (Novozymes) B a Buy or a Sell?